GGHC
APYX icon

Gilder Gagnon Howe & Co’s Apyx Medical APYX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-52,995
Closed -$276K – 266
2016
Q3 		$276K Buy
+52,995
New +$172K ﹤0.01% 220

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Gilder Gagnon Howe & Co's APYX Position: Q4 2016 in Review

Gilder Gagnon Howe & Co sold out of Apyx Medical (APYX) in Q4 2016, closing a stake of 52,995 shares — an estimated $276K sold.

Gilder Gagnon Howe & Co first reported a position in APYX in Q3 2016 and held it in 1 quarter. The position peaked at $276K in Q3 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q4 2016.

  • Gilder Gagnon Howe & Co reported no remaining Apyx Medical position as of Q4 2016 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 52,995 Apyx Medical shares in Q4 2016, an estimated $276K.
  • Gilder Gagnon Howe & Co first reported a position in Apyx Medical in Q3 2016 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's Apyx Medical position peaked at $276K in Q3 2016.
  • 39 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2016.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2016, filed 1 Feb 2017.